secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2025-03-12T23:59:59+00:00
Accession:  0001493152-25-010035
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaPro Therapeutics (2/3 owned by BriaCell) reports six-month net loss of $233K, cash only $1, going concern warning
--------------------------------------------------------------------------------

- Net loss for six months ended Jan 31, 2025: $233,185; accumulated deficit $673,394.
- Cash and cash equivalents only $1; total assets $192,161 mostly intangible patents.
- Current liabilities $658,049 due to related party (BriaCell); warrant liability $172,991.
- No revenue; R&D expenses $130,023, G&A $80,012 for six months.
- Going concern warning: material uncertainty about ability to raise capital to continue operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315225010035/0001493152-25-010035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315225010035/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-010035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer